Scopio Labs Receives EU IVDR Certification for AI-Powered Digital Morphology Platforms
The certification covers the company's X100 and X100HT platforms, including Full-Field Peripheral Blood Smear Application with RBC AI-powered decision support.
The certification covers the company's X100 and X100HT platforms, including Full-Field Peripheral Blood Smear Application with RBC AI-powered decision support.
High-resolution maps showed us where cells live; the next phase of spatial omics is about extracting those cells and uncovering the molecular conversations that shape outcomes.
Thermo Fisher Scientific has launched a kit enabling sequential extraction of protein, DNA, and RNA from a single sample, supporting multi-omics cancer research and downstream mass spectrometry and sequencing applications.
The automation-compatible system works with plasma, serum, urine and cerebrospinal fluid samples from 1 ml to 4 ml input volumes.
Castle Biosciences' AdvanceAD-Tx test identifies patients more likely to respond to JAK inhibitor therapy versus Th2-targeted treatments.